Well stated and again,unless anyone can think of a
Post# of 72440
Having these FDA meeting minutes in hand allows IPIX to complete the scientific advice needs from the EMA to move to their planned P3 B-OM in the US and EU.
At this point,B-OM is now "plug and play" or as some would say "turn key" ready.
I can think of nothing else that stands in the way of the planned P3 much less a partnership.
Kelt